Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950129-05-002133
Filing Date
2005-03-09
Accepted
2005-03-09 09:24:03
Documents
7
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 ENCYSIVE PHARMACEUTICALS INC.- DECEMBER 31, 2004 h23242e10vk.htm 10-K 693524
2 SUBSIDIARIES OF THE REGISTRANT h23242exv21w1.htm EX-21.1 4429
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM h23242exv23w1.htm EX-23.1 1815
4 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) h23242exv31w1.htm EX-31.1 7064
5 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) h23242exv31w2.htm EX-31.2 7450
6 CERTIFICATION PURSUANT TO SECTION 906 h23242exv32w1.htm EX-32.1 2860
7 CERTIFICATION PURSUANT TO SECTION 906 h23242exv32w2.htm EX-32.2 3169
  Complete submission text file 0000950129-05-002133.txt   722895
Mailing Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081
Business Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081 7137968822
ENCYSIVE PHARMACEUTICALS INC (Filer) CIK: 0000887023 (see all company filings)

EIN.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20117 | Film No.: 05668194
SIC: 2834 Pharmaceutical Preparations